No Detail Found!

Evaluation of Single Dose Sodium Polystyrene Sulfonate for Management of Hyperkalemia and its effect on Other Serum Electrolytes.

Author(s)
Shoaib Alam University of Karachi, Karachi, Pakistan
Azfar Athar Ishaqui University of Karachi, Karachi, Pakistan
Masood Ahmed Khan University of Karachi, Karachi, Pakistan
Adnan Iqbal University of Karachi, Karachi, Pakistan
Syed Hameez Jawed University of Karachi, Karachi, Pakistan
Farah Khalid University of Karachi, Karachi, Pakistan
Mir Muhammad Uzairullah University of Karachi, Karachi, Pakistan
Muhammad Talha Hamdard University Karachi, Pakistan
Usman Ashfaq Hamdard University Karachi, Pakistan
Najam Zehra Hamdard University Karachi, Pakistan
Abstract
Objective: To assess the effectiveness of sodium polystyrene sulphonate in treating hyperkalemia and its effect on different serum electrolytes level. Study Design: Quasi-experimental study. Place and Duration of Study: Lyari general hospital, 500 bedded tertiary care public sector hospital at Karachi, from Jan 2017 to Mar 2017. Material and Methods: Hyperkalemic patients were included in study who fulfilled inclusion criteria and were administered with single STAT 30 grams dose of Sodium Polystyrene Sulfonate. Serum electrolytes such as sodium, chloride, magnesium, phosphate and calcium were measured before and after 2 hours of administration of Sodium Polystyrene Sulfonate. Paired t-test was used as tool for statistical analysis. Results: Significant (p0.05). Conclusion: Sodium polystyrene sulphonate found to be effective in treating hyperkalemia and considerable changes in serum sodium level have been observed with minimal changes in serum magnesium and calcium levels.
Publication Details
Page(s) 37-42
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 69, Issue: 1, Year: 2019

Request the full text from PASTIC

Keywords
electrolytes level, Hperkalemia, Sodium polystyrene sulphonate Delete extra addresses
References
MeaneyCJ,BeccariMV,YangY,ZhaoJ, 2017.Systematic Review and Meta Analysis of Patiromer and Sodium Zirconium Cyclosilicate: A New Armamentarium for the Treatment of Hyperkalemia,Pharmacotherapy 37 401 -11
McCulloughPA,BeaverTM,Bennett-GuerreroE,EmmettM,FonarowGC,GoyalA, 2014.Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management,Rev Cardiovasc Med 15 11 -23
HaganAE,FarringtonCA,WallGC,BelzMM, 2016.Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study,Clin Nephrol 85 38 -43
YuMY,YeoJH,ParkJS,LeeCH,KimGH, 2017.Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients,PloS one 12 e0173542 -
LepageL,DufourAC,DoironJ,HandfieldK,DesforgesK,BellR, 2015.Randomized clinical trial of sodium polystyrene sulfonate for the treatment of mild hyperkalemia in CKD,Clin J Am Soc Nephro 10 2136 -42
ChaitmanM,DixitD,BridgemanMB, 2016.Potassium-binding agents for the clinical management of hyperkalemia, 41 43 -
LiL,HarrisonSD,CopeMJ,ParkC,LeeL,SalaymehF, 2016.Mechanism of action and pharmacology of patiromer, a nonabsorbed cross-linked polymer that lowers serum potassium concentration in patients with hyperkalemia,J Cardiovasc Pharm T 21 456 -65
ChenCC,ChenCA,ChauT,LinSH, 2005.Hypokalaemia and hypomagnesaemia in an oedematous diabetic patient with advanced renal failure,Nephrol Dial Transpl 20 2271 -73
PittB,AnkerSD,BushinskyDA,KitzmanDW,ZannadF,HuangIZ, 2011.Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebocontrolled study in patients with chronic heart failure (the PEARL-HF) trial,Eur Heart J 32 820 -28
NepalM,BucaloiuID,NorfolkER, 2010.Hypernatremia in a patient treated with sodium polystyrene sulfonate,Int J Nephrol Renovasc Dis 3 141 -
FilippiL,CecchiA,DaniC,BertiniG,PezzatiM,RubaltelliFF, 2004.Hypernatraemia induced by sodium polystyrene sulphonate (Kayexalate®) in two extremely low birth weight newborns,Pediatr Anesth 14 271 -75
CherninG,Gal OzA,Ben AssaE,SchwartzIF,WeinsteinT,SchwartzD, 2012.Secondary Prevention of Hyperkalemia With Sodium Polystyrene Sulfonate in Cardiac and Kidney Patients on Renin Angiotensin Aldosterone System Inhibition Therapy,Clin Cardiol 35 32 -36
KakajiwalaA,BartonKT,RampollaE,BreenC,Pradhan M. Acute, 2017.Hypocalcemia and Metabolic Alkalosis in Children on Cation-Exchange Resin Therapy,Case Rep Nephrol Dial -
BatterinkJ, 2015.Effectiveness of sodium polystyrene sulfonate for short-term treatment of hyperkalemia,Can J Hosp Pharm 68 296 -303
MistryM.,SheaA.,GiguereP, 2016.Evaluation of sodium polystyrene sulfonate dosing strategies in the inpatient management of hyperkalemia,Ann Pharmacother 50 455 -62
HarelZ,HarelS,ShahPS, 2013.Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review,Am J Med 126 264e9 -264e24
MountDB,KasperD,FauciA,HauserS,McGraw Hill Education, 2015.Potassium disorders,Harrison's Principles of Internal Medicine 295 -312
Lillemoe K.D.,RomoloJ.L.,HamiltonS.R., 1987.Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis,Surgery 101 267 -72
0

Citations

0

Downloads

105

Views